Pan, Hongchao; Peto, Richard; Karim, Quarraisha Abdool; Alejandria, Marissa M.; Henao-Restrepo, Ana-Maria; Hernández-García, César; Kieny, Marie-Paule; Malekzadeh, Reza; Murthy, Srinivas; Preziosi, Marie-Pierre; Reddy, K Srinath; Periago, Mirta Roses; Sathiyamoorthy, Vasee; Røttingen, John-Arne; Swaminathan, Soumya; Ryan, Michael; Maggioni, Aldo; Babiker, Abdel; Cook, Deborah; Dondorp, Arjen; Kang, Gagandeep; Aukrust, Pål; Barratt-Due, Andreas; Dalgard, Olav; Vinge, Leif Erik; Kittang, Bård Reiakvam; Blomberg, Bjørn; Ystrøm, Carl Magnus; Eiken, Ragnhild; Skei, Nina Vibeche; Hoel, Hedda; Tholin, Birgitte; Hoff, Dag Arne Lihaug; Dyrhol-Riise, Anne Ma; Holten, Aleksander Rygh; Kåsine, Trine; Nezvalova-Henriksen, Katerina; Olsen, Inge Christoffer; Trøseid, Marius; Aballi, Saad; Bjørkholt Olsen, Roy; Haugli, Mette; Berg, Åse; Skudal, Hilde Kristin; Hannula, Raisa; Kildal, Anders Benjamin; Johannessen, Asgeir; Tveita, Anders Aune; Heggelund, Lars; Ernst, Gernot Walter; Thoresen, Lars (Peer reviewed; Journal article, 2022)
Background
The Solidarity trial among COVID-19 inpatients has previously reported interim mortality analyses for four repurposed antiviral drugs. Lopinavir, hydroxychloroquine, and interferon (IFN)-β1a were discontinued ...